Ultrasight Raises $13 Million To Bring Ai Guidance For Cardiac Ultrasound To Patient Point Of Care

May 11, 2021•about 4 years ago

Amount Raised

$13 Million

Tel Aviv

Description

UltraSight (formerly OnSight Medical), a Digital Health pioneer for cardiac imaging and beyond, announced today that it has closed a $13 million Series B funding round. The investment will be used to advance U.S. clinical programs for its real time, AI guidance in a variety of care settings. The Yozma Group Korea, Atain Specialty Insurance Company and the Weizmann Institute of Science participated in the round.

Company Information

Company

Ultra Sight

Location

Tel Aviv, Tel Aviv District, Israel

About

UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere. UltraSight won the TCT 2020 Innovation Competition which took place during the Transcatheter Cardiovascular Therapeutics world conference. For more information please visit us at www.ultrasight.com

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Ultrasight Raises $13 Million To Bring Ai Guidance For Cardiac Ultrasound To Patient Point Of Care

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information